| Code | Description | Claims | Beneficiaries | Total Paid |
| 99241 |
|
3,490 |
2,877 |
$336K |
| 99242 |
|
978 |
828 |
$146K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
778 |
759 |
$90K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,537 |
1,170 |
$34K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,311 |
1,117 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,089 |
1,640 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,080 |
816 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,975 |
1,430 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
963 |
798 |
$2K |
| S9083 |
Global fee urgent care centers |
153 |
137 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
351 |
292 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
316 |
256 |
$576.48 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
275 |
166 |
$196.49 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
69 |
43 |
$109.55 |
| 94760 |
|
370 |
288 |
$57.20 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$25.65 |
| 87807 |
|
21 |
21 |
$20.12 |
| 81003 |
|
155 |
109 |
$13.08 |
| 81025 |
|
21 |
12 |
$0.00 |